kt-5000AI update: what we’ve shown, and what’s next

Preview text: kt-5000AI update: what we’ve shown, and what’s next kt-5000AI update: what we’ve shown…

Thursday, Oct 22, 2026 at 4:17 PM EasternMailchimp

Rakovina Therapeuticskt-5000AI update: what we’ve shown, and what’s next

Fit to screenFull size

Using this email in an article? Credit: Rakovina Therapeutics email via They Sent It, with a link to this page. Full-size image

Use this example

Subject: kt-5000AI update: what we’ve shown, and what’s next
Preview text: kt-5000AI update: what we’ve shown, and what’s next kt-5000AI update: what we’ve shown…
From: ir@rakovinatherapeutics.com
Brand: Rakovina Therapeutics
ESP: Mailchimp
Sent: Thu Oct 22, 2026, 4:17 PM ET
Size: 70 KB
Images: 7
Links: 13, 2 of them buttons
Subject length: 51 characters

Against Rakovina Therapeutics's usual

Sent in its busiest hour, 4 PM, which holds 31% of its emails. The subject is 51 characters; its average is 70.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

Other sending headers (names only): X-Campaign, X-campaignid, X-Report-Abuse, X-MC-User, X-Accounttype

	Nov 10, 2026 12:27 PM	Announcing our partnership with Artemis AI
	Nov 4, 2026 10:45 AM	Live tomorrow: the kt-5000AI story with Kim Oishi, Dr. Mads Daugaard and Handol Kim
	Oct 30, 2026 11:32 AM	AI narrows the focus for our brain-targeted cancer drug
	Oct 22, 2026 4:17 PM	kt-5000AI update: what we’ve shown, and what’s next (this email)
	Oct 18, 2026 4:14 PM	Rakovina secures exclusivity on kt-5000 target profile · Resent
	Oct 15, 2026 10:30 AM	Rakovina secures exclusivity on kt-5000 target profile
	Oct 1, 2026 4:18 PM	Rakovina partners with Celvion: what it means for our ATR program